Take a load offMexican tot recovering after removal of 33 lb. tumor

Evan Godt | | Health Imaging | Artificial Intelligence
surgical instruments - 194.90 Kb
A two-year-old boy in Mexico is recovering and reportedly doing well after doctors removed a 33 lb. benign tumor from his body.

The procedure, which occurred June 14, took doctors at La Raza Medical Center in Mexico City 10 hours to complete, according to the Associated Press. At the time of the surgery, the boy, Jesus Rodriguez, weighed less than the tumor at 26 lbs.

Gustavo Hernandez, MD, director of pediatrics at La Raza Medical Center, told the Associated Press the boy was born with the lump that eventually covered the right side of his body from armpit to hip. He also said the operation marks the first time Mexican doctors removed a tumor larger than the patient.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Related Content

AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
How AI and CCTA help heart teams plan ahead before PCI
5 steps for evaluating radiology AI applications
Adaptable AI system detects subtle changes in imaging, has potential across multiple clinical settings
New algorithm models radiologists' eye movements to interpret chest X-rays

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.